The present invention relates to novel heterocyclic compounds of formula (I) wherein the variables are as defined in the claims or the description which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), compositions containing the compounds their use for preparing a medicament for the treatment of a medical disorder susceptible to the treatment with a compound that modulates preferably inhibits the activity of glycogen synthase kinase 3 and methods of treatment of medical disorders susceptible to treatment with a compound that modulates glycogen synthase kinase 3 activity using the compounds.
